CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice
Volume 17, Issue 3

More Than a Box: Inside the Cold Chain’s Quiet Revolution

In today’s pharmaceutical and life sciences landscape, delivering a cold chain container is no longer enough. With the growing pressure to ensure product integri...
Continue Reading →
Volume 17, Issue 3

Complexity of Selling Orally Inhaled and Nasal Drug Product CDMO Services

Selling Contract Development and Manufacturing Organisation (CDMO) services is a complex task that demands a versatile skill set, encompassing drug development e...
Continue Reading →
Volume 17, Issue 3

INHALED mRNA: The Race Has Begun

With targeted delivery and potential for improved patient adherence, inhaled mRNA therapies are emerging as the new frontier in respiratory and genetic medicine....
Continue Reading →
Volume 17, Issue 3

Safely Navigating the Transition to Low-GWP Medical Propellants

The pressure to reduce greenhouse gas emissions has transformed nearly every industry, and respiratory pharmaceuticals is no exception. Pressurised metered d...
Continue Reading →
Volume 17, Issue 3

Scaling Capabilities in Nasal Drug Delivery

Nasal drug delivery has traditionally been used for local, inflammatory conditions within the sinus cavity, such as rhinitis and nasal congestion. In recent year...
Continue Reading →
Volume 17, Issue 3

Unveiling the Path of Nebuliser Platforms for Combination Product Development

With the objective to providing more efficient and user-friendly solutions for inhalation therapy, companies developing mesh nebulisers have adopted customisable pla...
Continue Reading →
Volume 17, Issue 3

The Role of Nasal Cast Testing in Drug Development

Nasal drug delivery has emerged as a major focus in pharmaceutical development because it combines convenience, rapid absorption, high bioavailability, and the p...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026